Skip to content

Artia Global Partners LP

Follow

13F filer, CIK 1937964, MIAMI, FL

Artia Global Partners LP reported $495,640,117 across 51 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16. Its ten largest share positions make up 63.23% of the portfolio.

Accepted , ingested 13F-HR 0001937964-26-000011

Period
2026-09-30
Reported value
$496M
Holdings
51
Top 10 weight
63.23%
New
13
Sold out
10

Largest buys vs the previous quarter

SecurityShares changeApprox. value
RVTYnew+80,948$12.4M
GHadded+58,604$10.5M
BRKRnew+103,796$6.72M
BTSGadded+92,629$5.26M
TMOnew+7,610$5.14M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
ABVXreduced-152,179-$15.1M
IONSexited-144,376-$11.4M
ALMSexited-278,546-$7.84M
SIONexited-119,741-$5.27M
PALIexited-1,992,367-$4.16M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001937964-26-000011, largest first. % of portfolio is the value over $491,788,717, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
INSMINSMED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 167,939 shares; 2025Q1: 318,239 shares; 2025Q2: 752,712 shares; 2025Q3: 732,212 shares; 2025Q4: 682,212 shares; 2026Q1: 628,712 shares; 2026Q2: 589,052 shares; 2026Q3: 589,052 shares 589,052$67.2M13.67%0Timeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 284,190 shares; 2025Q1: 104,190 shares; 2025Q2: 104,190 shares; 2025Q3: 104,190 shares; 2025Q4: 104,190 shares; 2026Q1: 124,990 shares; 2026Q2: 185,390 shares; 2026Q3: 185,390 shares 185,390$38.1M7.74%0Timeline
ABVXABIVAX SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 225,453 shares; 2025Q4: 600,747 shares; 2026Q1: 600,747 shares; 2026Q2: 516,447 shares; 2026Q3: 364,268 shares 364,268$36.1M7.33%-152,179Timeline
BTSGBRIGHTSPRING HEALTH SVCS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 41,600 shares; 2025Q4: 41,600 shares; 2026Q1: 53,800 shares; 2026Q2: 517,315 shares; 2026Q3: 609,944 shares 609,944$34.6M7.04%+92,629Timeline
TRVITREVI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 1,311,840 shares; 2025Q3: 1,999,702 shares; 2025Q4: 2,013,602 shares; 2026Q1: 2,013,602 shares; 2026Q2: 2,210,852 shares; 2026Q3: 2,210,852 shares 2,210,852$31.7M6.44%0Timeline
ARGXARGENX SEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 11,311 shares; 2025Q1: 11,311 shares; 2025Q2: 78,311 shares; 2025Q3: 78,311 shares; 2025Q4: 64,699 shares; 2026Q1: 29,739 shares; 2026Q2: 29,739 shares; 2026Q3: 29,739 shares 29,739$28.5M5.8%0Timeline
TVTXTRAVERE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 30,900 shares; 2025Q2: 30,900 shares; 2025Q3: 30,900 shares; 2025Q4: 70,700 shares; 2026Q1: 70,700 shares; 2026Q2: 339,033 shares; 2026Q3: 398,493 shares 398,493$23.5M4.77%+59,460Timeline
ALKSALKERMES PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 448,964 shares; 2026Q3: 448,964 shares 448,964$18.2M3.7%0Timeline
GHGUARDANT HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 38,100 shares; 2026Q3: 96,704 shares 96,704$17.2M3.51%+58,604Timeline
AZNASTRAZENECA PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 95,376 shares; 2026Q2: 98,376 shares; 2026Q3: 98,376 shares 98,376$15.9M3.23%0Timeline
DGXQUEST DIAGNOSTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 56,717 shares; 2025Q2: 81,717 shares; 2025Q3: 81,717 shares; 2025Q4: 40,817 shares; 2026Q1: 40,817 shares; 2026Q2: 65,122 shares; 2026Q3: 65,122 shares 65,122$15.2M3.09%0Timeline
DNTHDIANTHUS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 108,723 shares; 2025Q4: 205,090 shares; 2026Q1: 162,990 shares; 2026Q2: 162,990 shares; 2026Q3: 165,735 shares 165,735$14.6M2.97%+2,745Timeline
RVTYREVVITY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 80,948 shares 80,948$12.4M2.52%newTimeline
NAMSNEWAMSTERDAM PHARMA COMPANYQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 54,285 shares; 2025Q1: not reported; 2025Q2: 27,319 shares; 2025Q3: 194,838 shares; 2025Q4: 503,936 shares; 2026Q1: 503,936 shares; 2026Q2: 503,936 shares; 2026Q3: 503,936 shares 503,936$12.3M2.49%0Timeline
MRKMERCK & CO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 46,700 shares; 2026Q2: 46,700 shares; 2026Q3: 80,500 shares 80,500$11.7M2.38%+33,800Timeline
JNJJOHNSON & JOHNSONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 22,600 shares; 2026Q2: 22,600 shares; 2026Q3: 27,100 shares 27,100$7.17M1.46%+4,500Timeline
BRKRBRUKER CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 103,796 shares 103,796$6.72M1.37%newTimeline
BIIBBIOGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 18,437 shares; 2026Q2: 18,437 shares; 2026Q3: 29,237 shares 29,237$6.6M1.34%+10,800Timeline
EWTXEDGEWISE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 65,500 shares; 2026Q2: 98,800 shares; 2026Q3: 161,175 shares 161,175$6.54M1.33%+62,375Timeline
VKTXVIKING THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 90,279 shares; 2025Q1: 90,279 shares; 2025Q2: 96,479 shares; 2025Q3: 146,179 shares; 2025Q4: 719,365 shares; 2026Q1: 180,731 shares; 2026Q2: 180,731 shares; 2026Q3: 180,731 shares 180,731$5.89M1.2%0Timeline
RAPPRAPPORT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 64,608 shares; 2025Q4: 138,508 shares; 2026Q1: 138,508 shares; 2026Q2: 138,508 shares; 2026Q3: 166,508 shares 166,508$5.59M1.14%+28,000Timeline
TMOTHERMO FISHER SCIENTIFIC INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 7,610 shares 7,610$5.14M1.04%newTimeline
ABSIABSCI CORPORATIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 464,444 shares; 2026Q3: 464,444 shares 464,444$5M1.02%0Timeline
ROIVROIVANT SCIENCES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 129,800 shares; 2026Q1: 129,800 shares; 2026Q2: 129,800 shares; 2026Q3: 129,800 shares 129,800$4.75M0.97%0Timeline
CYTKCYTOKINETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 16,300 shares; 2026Q2: 70,700 shares; 2026Q3: 70,700 shares 70,700$4.66M0.95%0Timeline
SRRKSCHOLAR ROCK HLDG CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 172,185 shares; 2025Q2: 126,285 shares; 2025Q3: 96,285 shares; 2025Q4: 96,285 shares; 2026Q1: 96,285 shares; 2026Q2: 96,285 shares; 2026Q3: 96,285 shares 96,285$4.65M0.95%0Timeline
BLTEBELITE BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 17,989 shares; 2026Q1: 24,989 shares; 2026Q2: 24,989 shares; 2026Q3: 24,989 shares 24,989$4.24M0.86%0Timeline
TXG10X GENOMICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 46,300 shares 46,300$4.18M0.85%newTimeline
ASNDASCENDIS PHARMA A/SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 17,740 shares; 2026Q3: 17,740 shares 17,740$4.04M0.82%0Timeline
CELCCELCUITY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 12,900 shares; 2026Q1: 15,576 shares; 2026Q2: 59,316 shares; 2026Q3: 50,522 shares 50,522$4.02M0.82%-8,794Timeline
GRALGRAIL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 25,200 shares 25,200$3.53M0.72%newTimeline
MLYSMINERALYS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 41,100 shares; 2025Q3: 56,600 shares; 2025Q4: 137,800 shares; 2026Q1: 137,800 shares; 2026Q2: 137,800 shares; 2026Q3: 137,800 shares 137,800$3.46M0.7%0Timeline
ELVNENLIVEN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 102,900 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 20,900 shares; 2026Q2: 72,100 shares; 2026Q3: 72,100 shares 72,100$3.31M0.67%0Timeline
PTGXPROTAGONIST THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 293,851 shares; 2025Q1: 333,851 shares; 2025Q2: 22,951 shares; 2025Q3: 22,951 shares; 2025Q4: 22,951 shares; 2026Q1: 22,931 shares; 2026Q2: 22,951 shares; 2026Q3: 22,951 shares 22,951$3.23M0.66%0Timeline
TWSTTWIST BIOSCIENCE CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 15,300 shares 15,300$2.96M0.6%newTimeline
ORKAORUKA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 7,380 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 33,400 shares; 2026Q3: 33,400 shares 33,400$2.78M0.57%0Timeline
UTHRUNITED THERAPEUTICS CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 5,000 shares; 2025Q2: 5,000 shares; 2025Q3: 5,000 shares; 2025Q4: 5,000 shares; 2026Q1: 5,000 shares; 2026Q2: 5,000 shares; 2026Q3: 5,000 shares 5,000$2.71M0.55%0Timeline
KNSAKINIKSA PHARMACEUTICALS INTLQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 29,200 shares; 2025Q3: 29,200 shares; 2025Q4: 29,200 shares; 2026Q1: 29,200 shares; 2026Q2: 29,200 shares; 2026Q3: 29,200 shares 29,200$2.18M0.44%0Timeline
CORTCORCEPT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 18,000 shares 18,000$2.07M0.42%newTimeline
DRUGBRIGHT MINDS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 33,407 shares; 2026Q1: 38,407 shares; 2026Q2: 38,407 shares; 2026Q3: 38,407 shares 38,407$1.91M0.39%0Timeline
EYPTEYEPOINT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 216,700 shares; 2025Q1: 316,700 shares; 2025Q2: 316,700 shares; 2025Q3: 628,367 shares; 2025Q4: 767,098 shares; 2026Q1: 767,098 shares; 2026Q2: 767,098 shares; 2026Q3: 464,698 shares 464,698$1.52M0.31%-302,400Timeline
RXRXRECURSION PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 334,402 shares 334,402$1.38M0.28%newTimeline
AAGILENT TECHNOLOGIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 5,800 shares 5,800$999K0.2%newTimeline
PROKPROKIDNEY CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,838,411 shares; 2026Q1: 1,806,939 shares; 2026Q2: 1,806,939 shares; 2026Q3: 553,744 shares 553,744$919K0.19%-1,253,195Timeline
PRAXPRAXIS PRECISION MEDICINES IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 2,500 shares; 2026Q1: 2,500 shares; 2026Q2: 2,500 shares; 2026Q3: 2,500 shares 2,500$728K0.15%0Timeline
PEPGPEPGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 205,324 shares; 2026Q1: 205,324 shares; 2026Q2: 205,324 shares; 2026Q3: 205,324 shares 205,324$497K0.1%0Timeline
MBXMBX BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 8,300 shares 8,300$487K0.1%newTimeline
SYRESPYRE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 4,000 shares; 2026Q3: 4,000 shares 4,000$356K0.07%0Timeline
DNAGINKGO BIOWORKS HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 20,444 shares 20,444$262K0.05%newTimeline
CLYMCLIMB BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 21,097 shares 21,097$242K0.05%newTimeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
MRNAMODERNA INC COMput20,000$3.85Mnew

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
XBISPDR SERIES TRUST100,000$15.8Mput
IONSIONIS PHARMACEUTICALS INC144,376$11.4Mshares
ALMSALUMIS INC278,546$7.84Mshares
SIONSIONNA THERAPEUTICS INC119,741$5.27Mshares
PALIPALISADE BIO INC1,992,367$4.16Mshares
XENEXENON PHARMACEUTICALS INC65,000$3.92Mshares
CMPXCOMPASS THERAPEUTICS INC383,200$839Kshares
KODKODIAK SCIENCES INC17,019$663Kshares
TENXTENAX THERAPEUTICS INC42,080$612Kshares
NUVLNUVALENT INC4,900$605Kshares

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001937964-26-000011 base2026-11-16